WO2000009709A3 - Proteases et proteines associees - Google Patents
Proteases et proteines associees Download PDFInfo
- Publication number
- WO2000009709A3 WO2000009709A3 PCT/US1999/017818 US9917818W WO0009709A3 WO 2000009709 A3 WO2000009709 A3 WO 2000009709A3 US 9917818 W US9917818 W US 9917818W WO 0009709 A3 WO0009709 A3 WO 0009709A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pprg
- associated proteins
- proteases
- provides
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99939042A EP1104473A2 (fr) | 1998-08-10 | 1999-08-06 | Proteases et proteines associees |
AU53403/99A AU5340399A (en) | 1998-08-10 | 1999-08-06 | Proteases and associated proteins |
CA002338386A CA2338386A1 (fr) | 1998-08-10 | 1999-08-06 | Proteases et proteines associees |
JP2000565144A JP2002522081A (ja) | 1998-08-10 | 1999-08-06 | プロテアーゼ及び関連タンパク質 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9611498P | 1998-08-10 | 1998-08-10 | |
US60/096,114 | 1998-08-10 | ||
US11976899P | 1999-02-11 | 1999-02-11 | |
US60/119,768 | 1999-02-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000009709A2 WO2000009709A2 (fr) | 2000-02-24 |
WO2000009709A3 true WO2000009709A3 (fr) | 2000-09-08 |
Family
ID=26791134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/017818 WO2000009709A2 (fr) | 1998-08-10 | 1999-08-06 | Proteases et proteines associees |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1104473A2 (fr) |
JP (1) | JP2002522081A (fr) |
AU (1) | AU5340399A (fr) |
CA (1) | CA2338386A1 (fr) |
WO (1) | WO2000009709A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6919433B2 (en) | 1997-03-14 | 2005-07-19 | Human Genome Sciences, Inc. | Antibodies to protein HPMBQ91 |
US6951924B2 (en) | 1997-03-14 | 2005-10-04 | Human Genome Sciences, Inc. | Antibodies against secreted protein HTEBYII |
JP2001524814A (ja) | 1997-03-14 | 2001-12-04 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | 28種類のヒト分泌タンパク質 |
JP2002532054A (ja) | 1997-08-29 | 2002-10-02 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 29個のヒト分泌タンパク質 |
WO1999058668A1 (fr) * | 1998-05-14 | 1999-11-18 | Ono Pharmaceutical Co., Ltd. | Nouveaux polypeptides, adn complementaires les codant et utilisation de ces polypeptides |
EP1080209A2 (fr) * | 1998-10-21 | 2001-03-07 | Arch Development Corporation | Procede de traitement des diabetes de type 2 |
JP2003125777A (ja) * | 1999-04-27 | 2003-05-07 | Jenokkusu Soyaku Kenkyusho:Kk | 花粉症関連遺伝子、581 |
EP1238281A2 (fr) * | 1999-12-01 | 2002-09-11 | Ludwig Institute For Cancer Research | Antigenes associes au cancer et utilisations correspondantes |
WO2001064919A2 (fr) * | 2000-02-28 | 2001-09-07 | Millennium Pharmaceuticals, Inc. | 18036, une nouvelle protease semblable a la calpaïne, et utilisations de celle-la |
WO2001088157A2 (fr) * | 2000-05-16 | 2001-11-22 | Millennium Pharmaceuticals, Inc. | Methodes de traitement avec 17906 et utilisations de celles-ci |
JP2004523212A (ja) * | 2000-09-08 | 2004-08-05 | インサイト・ゲノミックス・インコーポレイテッド | プロテアーゼ |
WO2002026955A2 (fr) * | 2000-09-29 | 2002-04-04 | Lexicon Genetics Incorporated | Nouvelles proteases humaines et polynucleotides codant pour ces proteases |
WO2002053754A2 (fr) * | 2001-01-08 | 2002-07-11 | Lexicon Genetics Incorporated | Nouvelle protease humaine et polynucleotides codant cette derniere |
EP1532161B1 (fr) | 2002-06-13 | 2012-02-15 | Novartis Vaccines and Diagnostics, Inc. | Vecteurs pour l'expression de polypeptides hml-2 |
WO2004104218A1 (fr) * | 2003-05-23 | 2004-12-02 | Bayer Healthcare Ag | Agents diagnostiques et therapeutiques destines a des maladies associees a x-prolyl aminopeptidase 1 (xpnpep1) |
WO2008012476A2 (fr) * | 2006-07-26 | 2008-01-31 | L'oreal | Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique |
FR2904223B1 (fr) * | 2006-07-26 | 2013-01-11 | Oreal | Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique |
DE102009010942A1 (de) * | 2009-02-27 | 2010-09-02 | Universitätsklinikum Schleswig-Holstein | Serinprotease-Inhibitoren zur spezifischen Inhibition von Gewebs-Kallikreinen |
JP5728743B2 (ja) * | 2009-03-30 | 2015-06-03 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 関節リウマチの診断のためのバイオマーカー、方法およびキット |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996004387A1 (fr) * | 1994-08-02 | 1996-02-15 | Roussel Uclaf | Sequences d'adn codant pour les proteines humaines tx et ty apparentees a l'enzyme de conversion de l'interleukine-1beta |
-
1999
- 1999-08-06 AU AU53403/99A patent/AU5340399A/en not_active Abandoned
- 1999-08-06 JP JP2000565144A patent/JP2002522081A/ja active Pending
- 1999-08-06 WO PCT/US1999/017818 patent/WO2000009709A2/fr not_active Application Discontinuation
- 1999-08-06 EP EP99939042A patent/EP1104473A2/fr not_active Withdrawn
- 1999-08-06 CA CA002338386A patent/CA2338386A1/fr not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996004387A1 (fr) * | 1994-08-02 | 1996-02-15 | Roussel Uclaf | Sequences d'adn codant pour les proteines humaines tx et ty apparentees a l'enzyme de conversion de l'interleukine-1beta |
Non-Patent Citations (3)
Title |
---|
BERNOT ET AL.: "A transcriptional map of the FMF region", GENOMICS, vol. 50, 1998, pages 147 - 160, XP002090815 * |
BERNOT ET AL.: "Homo sapiens mRNA for metalloproteinase", EMBL SEQUENCE DATABASE, 21 January 1998 (1998-01-21), HEIDELBERG DE, XP002129491 * |
BERNOT ET AL.: "Metalloproteinase", EMBL SEQUENCE DATABASE, 1 June 1998 (1998-06-01), HEIDELBERG DE, XP002129490 * |
Also Published As
Publication number | Publication date |
---|---|
CA2338386A1 (fr) | 2000-02-24 |
JP2002522081A (ja) | 2002-07-23 |
WO2000009709A2 (fr) | 2000-02-24 |
AU5340399A (en) | 2000-03-06 |
EP1104473A2 (fr) | 2001-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001012662A3 (fr) | Proteines associees a la membrane | |
WO1999061471A3 (fr) | Proteines transmembranaires humaines | |
WO1999036550A3 (fr) | Molecules de proteases humaines | |
WO2000015793A3 (fr) | Proteines gpcr humaines | |
WO2000021988A3 (fr) | Proteine humaine de la famille des ankyrines | |
WO2000034477A3 (fr) | Proteines associees a des neurones | |
WO2000018922A3 (fr) | Proteines humaines associees a des glucides | |
WO2000009709A3 (fr) | Proteases et proteines associees | |
WO1999058692A3 (fr) | Proteines associees a l'apoptose humaine | |
WO2000012711A3 (fr) | Proteines membranaires de canal humaines | |
WO2000029583A3 (fr) | Proteines de la superfamille des immunoglobulines | |
WO2000012703A3 (fr) | Molecules associees au transport de proteines | |
WO2000017355A3 (fr) | Proteines humaines associees au cytosquelette | |
WO2001020004A3 (fr) | Proteines phosphatase et proteines kinase | |
WO1999049038A3 (fr) | Proteines de fixation du calcium humaines | |
WO2000014251A3 (fr) | Transferases humaines | |
WO2000052151A3 (fr) | Proteines de secretion humaines | |
WO1999058558A3 (fr) | Proteines de signalisation cellulaire | |
WO1999061614A3 (fr) | Proteines socs humaines | |
WO2000031263A3 (fr) | Proteines associees a la gtpase | |
WO2000028045A3 (fr) | Hydrolases humaines | |
WO2000042201A3 (fr) | Peptidases humaines | |
WO2000023589A3 (fr) | Proteines associees a la proliferation et a l'apoptose | |
WO2000008155A3 (fr) | Proteines associees a un recepteur humain | |
WO1999049037A3 (fr) | Molecules apparentees a la proteine-phosphatase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2338386 Country of ref document: CA Ref country code: CA Ref document number: 2338386 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999939042 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999939042 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999939042 Country of ref document: EP |